Caution:At present, there are occasional discrepancies in the display of intellectual property rights holders and their representatives. We are working on a solution.
see.ip - Details for CHINAZOLIN-8-YL-DERIVATE ZUR BEHANDLUNG VON MELANOMEN, NICHT-KLEINZELLIGER LUNGENKREBS, SCHILDDRÜSENKREBS, EIERSTOCKKREBS ODER DICKDARMKREBS
Details for 2019157227
Up to date per 13.06.2026
Actions
Details for 2019157227
Title / Product Name
CHINAZOLIN-8-YL-DERIVATE ZUR BEHANDLUNG VON MELANOMEN, NICHT-KLEINZELLIGER LUNGENKREBS, SCHILDDRÜSENKREBS, EIERSTOCKKREBS ODER DICKDARMKREBS
Status
Deleted
Protection Type
European Patent
(AT-) Application Number
2019157227
EP Publication Number
3508204
E-Number
1885113
Language
EN
PCT Number
Publication Date
10.07.2019 A
11.02.2026 B1
Registration Date
11.02.2026
AT Publication Date
15.03.2026
Application Date
22.08.2014
Registration Number
-
Priorities
23.08.2013
US
201361869596 P
05.11.2013
US
201361900283 P
20.05.2014
US
201462000946 P
IPC
A61K 31/519 20060101AFI20190527BHEP
Maximum Duration of Protection
22.08.2034
Owner
Neupharma, Inc.1175 Chess Drive Suite 206 Foster City, CA 94404US
Representative
No representatives present
Inventor
QIAN, Xiangping114 Mira Street Foster City, CA 94404US
ZHU, Yong-Liang41077 Pementel Court Fremont, CA 94539US